US Patent Issued to BIOVERATIV THERAPEUTICS, SWEDISH ORPHAN BIOVITRUM on March 25 for "Methods of inducing immune tolerance to clotting factors" (Swedish, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,288, issued on March 25, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.) and SWEDISH ORPHAN BIOVITRUM AB (Stockholm).

"Methods of inducing immune tolerance to clotting factors" was invented by Jennifer Dumont (Waltham, Mass.), Nisha Jain (Waltham, Mass.) and Stefan Lethagen (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods inducing immune tolerance in a human, comprising administering to the human an effective amount of a composition or a chimeric protein comprising a clotting factor and an Fc region."

The patent was filed on Dec. 1, 2017, under Application No. 16/464,105.

*For further...